Bio Key International (BKYI) Cost of Revenue (2016 - 2025)
Bio Key International (BKYI) has disclosed Cost of Revenue for 16 consecutive years, with $357988.0 as the latest value for Q3 2025.
- Quarterly Cost of Revenue fell 23.03% to $357988.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Sep 2025, down 53.72% year-over-year, with the annual reading at $1.3 million for FY2024, 79.61% down from the prior year.
- Cost of Revenue hit $357988.0 in Q3 2025 for Bio Key International, down from $464180.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $1.9 million in Q4 2023 to a low of $239569.0 in Q2 2021.
- Historically, Cost of Revenue has averaged $675112.4 across 5 years, with a median of $393783.0 in 2022.
- Biggest five-year swings in Cost of Revenue: skyrocketed 516.95% in 2021 and later plummeted 86.34% in 2024.
- Year by year, Cost of Revenue stood at $372051.0 in 2021, then surged by 164.59% to $984393.0 in 2022, then skyrocketed by 95.1% to $1.9 million in 2023, then tumbled by 86.34% to $262360.0 in 2024, then surged by 36.45% to $357988.0 in 2025.
- Business Quant data shows Cost of Revenue for BKYI at $357988.0 in Q3 2025, $464180.0 in Q2 2025, and $279498.0 in Q1 2025.